A (PK) Study in Scarlet: Investigating Target Concentrations | Paolo Denti

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Harmonization of DDI Guidelines Among Different Regulatory Agencies: Challenges and Opportunities | Elin Lindhagen

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Harmonization of DDI Guidelines Among Different Regulatory Agencies | Elin Lindhagen

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

GSK - ViiV Healthcare | Jon Collins

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Shionogi Inc. | Simon Portsmouth

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Tissue-Specific Pharmacology: How Clinically Important Is It | Saye Khoo

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Opening Lecture: News in Antiviral Pharmacology: A Year in Review | Andrea Calcagno

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios during Pregnancy and Postpartum | Tim Cressey

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ? | Catia Marzolini,

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim Cressey

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Tissue-Specific Pharmacology Knowledge and Knowledge Gaps | Charles Flexner

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

New(er) Antiretrovirals in Pregnancy and Breastfeeding | Catriona Waitt

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy | Mike Emerson

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

A Year of CAB/RPV Use, What Have We Learned in the Real World | Emma Rubenstein

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Case Presentation - Complex DDI case | Dario Cattaneo

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Is TDM Still Needed / Useful ? | Nancy Sheehan

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

The Use of AI in Clinical Pharmacology | Lauren Walker

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs | Alice K. Pau

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023